U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137832) titled 'OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular Treatment for Medium Vessel Occlusion' on Aug. 15.
Brief Summary: PEARL-MeVO is an investigator-initiated, multicenter, prospective, randomized controlled, open-label, blinded endpoint (PROBE) clinical trial aiming at evaluating the efficacy and safety of intra-arterial thrombolysis as adjunct to endovascular treatment in improving 90-day functional outcome in acute ischemic stroke patients due to medium vessel occlusion (MeVO) within 24 hours of symptom onset.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Acute Ischemic Stroke
I...